The global peptide therapeutics market was valued at nearly $50 billion in 2024, and its projected to reach up to around $84 billion by 2034.1 One of the most well-known peptides in recent years is semaglutide (Ozempic), a glucagon-like peptide-1 receptor agonist (GLP-1) used for the treatment of type 2 diabetes.2 However, semaglutide is just one of many different peptides that could potentially lead to health benefits
PLoS ONE 6 , e17574 (2011)
More serious but less common risks include pancreatitis, gallbladder disease, and in people with type 2 diabetes potential worsening of diabetic retinopathy
Returning to your normal activities immediately after the treatment is generally possible
This route is often chosen when the goal is to influence system-wide immune activity and inflammation , which may also affect the brain indirectly through immune signaling
Impurities 1.0% (see CoA)